The Effect of Vitamin D SNP FokI (rs2228570) and ApaI (rs7975232) on Axial Spondyloarthritis in Patients on Biological Treatment Article Swipe

PDF

Abdullah H. Drewil , Manal Kamal Rasheed , Nizar Abdulateef Jassim ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.60110/medforum.360915

Objective: Examine associations between FokI and ApaI genotypes and axSpA disease activity, extra‐articular manifestations (EAMs), and infliximab (INF) response in Iraqi patients. Study Design: Cross-sectional studyPlace and Duration of Study: This study was conducted at the Baghdad Tertiary Centers from 1st August 2024 to 3th December 2024. Methods: This cross-sectional analysis of 150 axSpA patients on INF (≥3 months) at Baghdad Tertiary Centers. Disease activity was staged by ASDAS; genotypes were determined by PCR‐RFLP. Logistic models adjusted for age, sex, smoking, and disease duration assessed genotype-phenotype links; serum VDR activity and an INF “effect‐length” index were evaluated. Results: The mean age 38.8±8.9 years; 72% male; smokers 30%. FokI showed CC 60% and CT 40% (TT absent). CC was confined to inactive ASDAS and associated with remission (OR 19.2; p=0.04), whereas CT increased odds of high activity (OR 3.27; p=0.001). CT carriers had lower frequencies of uveitis, dactylitis, and UTI. ApaI genotypes did not associate with ASDAS or EAMs. Neither SNP related to serum VDR activity or INF effect‐length. Conclusions: FokI acts as a phenotypic modifier—CC protective for axial activity; CT associated with higher activity yet fewer select EAMs-while ApaI appears neutral. Pharmacodynamic measures were unaffected.

Related Topics

Vitamin B12 Deficiency

Principle Of Double Effect

Concepts

No concepts available.

Metadata

Type: article
Landing Page: https://doi.org/10.60110/medforum.360915
PDF: https://medicalforummonthly.com/index.php/mfm/article/download/5408/4827
OA Status: diamond
OpenAlex ID: https://openalex.org/W4415506792

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4415506792

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.60110/medforum.360915

Digital Object Identifier
Title: The Effect of Vitamin D SNP FokI (rs2228570) and ApaI (rs7975232) on Axial Spondyloarthritis in Patients on Biological Treatment

Work title
Type: article

OpenAlex work type
Publication year: 2025

Year of publication
Publication date: 2025-10-24

Full publication date if available
Authors: Abdullah H. Drewil, Manal Kamal Rasheed, Nizar Abdulateef Jassim

List of authors in order
Landing page: https://doi.org/10.60110/medforum.360915

Publisher landing page
PDF URL: https://medicalforummonthly.com/index.php/mfm/article/download/5408/4827

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: diamond

Open access status per OpenAlex
OA URL: https://medicalforummonthly.com/index.php/mfm/article/download/5408/4827

Direct OA link when available
Cited by: 0

Total citation count in OpenAlex

Full payload

id	https://openalex.org/W4415506792
doi	https://doi.org/10.60110/medforum.360915
ids.doi	https://doi.org/10.60110/medforum.360915
ids.openalex	https://openalex.org/W4415506792
fwci	0.0
type	article
title	The Effect of Vitamin D SNP FokI (rs2228570) and ApaI (rs7975232) on Axial Spondyloarthritis in Patients on Biological Treatment
biblio.issue	9
biblio.volume	36
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11092
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9894000291824341
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2745
topics[0].subfield.display_name	Rheumatology
topics[0].display_name	Spondyloarthritis Studies and Treatments
topics[1].id	https://openalex.org/T10469
topics[1].field.id	https://openalex.org/fields/24
topics[1].field.display_name	Immunology and Microbiology
topics[1].score	0.948199987411499
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/2403
topics[1].subfield.display_name	Immunology
topics[1].display_name	Psoriasis: Treatment and Pathogenesis
topics[2].id	https://openalex.org/T14028
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9241999983787537
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2736
topics[2].subfield.display_name	Pharmacology
topics[2].display_name	Healthcare and Venom Research
is_xpac	False
apc_list
apc_paid
language
locations[0].id	doi:10.60110/medforum.360915
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4387291296
locations[0].source.issn	1029-385X, 2519-7134
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	1029-385X
locations[0].source.is_core	False
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Medical Forum Monthly
locations[0].source.host_organization
locations[0].source.host_organization_name
locations[0].source.host_organization_lineage
locations[0].license	cc-by
locations[0].pdf_url	https://medicalforummonthly.com/index.php/mfm/article/download/5408/4827
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Medical Forum Monthly
locations[0].landing_page_url	https://doi.org/10.60110/medforum.360915
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5098528233
authorships[0].author.orcid
authorships[0].author.display_name	Abdullah H. Drewil
authorships[0].author_position	first
authorships[0].raw_author_name	Abdullah H. Drewil
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5063078797
authorships[1].author.orcid
authorships[1].author.display_name	Manal Kamal Rasheed
authorships[1].author_position	middle
authorships[1].raw_author_name	Manal K. Rasheed
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5028962066
authorships[2].author.orcid	https://orcid.org/0000-0003-0659-8130
authorships[2].author.display_name	Nizar Abdulateef Jassim
authorships[2].author_position	last
authorships[2].raw_author_name	Nizar A. Jassim
authorships[2].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://medicalforummonthly.com/index.php/mfm/article/download/5408/4827
open_access.oa_status	diamond
open_access.any_repository_has_fulltext	False
created_date	2025-10-24T00:00:00
display_name	The Effect of Vitamin D SNP FokI (rs2228570) and ApaI (rs7975232) on Axial Spondyloarthritis in Patients on Biological Treatment
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11092
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9894000291824341
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2745
primary_topic.subfield.display_name	Rheumatology
primary_topic.display_name	Spondyloarthritis Studies and Treatments
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.60110/medforum.360915
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4387291296
best_oa_location.source.issn	1029-385X, 2519-7134
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	1029-385X
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Medical Forum Monthly
best_oa_location.source.host_organization
best_oa_location.source.host_organization_name
best_oa_location.source.host_organization_lineage
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://medicalforummonthly.com/index.php/mfm/article/download/5408/4827
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Medical Forum Monthly
best_oa_location.landing_page_url	https://doi.org/10.60110/medforum.360915
primary_location.id	doi:10.60110/medforum.360915
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4387291296
primary_location.source.issn	1029-385X, 2519-7134
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	1029-385X
primary_location.source.is_core	False
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Medical Forum Monthly
primary_location.source.host_organization
primary_location.source.host_organization_name
primary_location.source.host_organization_lineage
primary_location.license	cc-by
primary_location.pdf_url	https://medicalforummonthly.com/index.php/mfm/article/download/5408/4827
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Medical Forum Monthly
primary_location.landing_page_url	https://doi.org/10.60110/medforum.360915
publication_date	2025-10-24
publication_year	2025
referenced_works_count	0
abstract_inverted_index.a	172
abstract_inverted_index.CC	109, 116
abstract_inverted_index.CT	112, 130, 139, 179
abstract_inverted_index.an	91
abstract_inverted_index.as	171
abstract_inverted_index.at	34, 59
abstract_inverted_index.by	67, 72
abstract_inverted_index.in	19
abstract_inverted_index.of	28, 51, 133, 144
abstract_inverted_index.on	55
abstract_inverted_index.or	156, 165
abstract_inverted_index.to	43, 119, 161
abstract_inverted_index.(OR	126, 136
abstract_inverted_index.(TT	114
abstract_inverted_index.150	52
abstract_inverted_index.1st	40
abstract_inverted_index.3th	44
abstract_inverted_index.40%	113
abstract_inverted_index.60%	110
abstract_inverted_index.72%	103
abstract_inverted_index.INF	56, 92, 166
abstract_inverted_index.SNP	159
abstract_inverted_index.The	98
abstract_inverted_index.VDR	88, 163
abstract_inverted_index.age	100
abstract_inverted_index.and	5, 8, 15, 26, 81, 90, 111, 122, 147
abstract_inverted_index.did	151
abstract_inverted_index.for	77, 176
abstract_inverted_index.had	141
abstract_inverted_index.not	152
abstract_inverted_index.the	35
abstract_inverted_index.was	32, 65, 117
abstract_inverted_index.yet	184
abstract_inverted_index.2024	42
abstract_inverted_index.30%.	106
abstract_inverted_index.ApaI	6, 149, 188
abstract_inverted_index.FokI	4, 107, 169
abstract_inverted_index.This	30, 48
abstract_inverted_index.UTI.	148
abstract_inverted_index.acts	170
abstract_inverted_index.age,	78
abstract_inverted_index.from	39
abstract_inverted_index.high	134
abstract_inverted_index.mean	99
abstract_inverted_index.odds	132
abstract_inverted_index.sex,	79
abstract_inverted_index.were	70, 95, 193
abstract_inverted_index.with	124, 154, 181
abstract_inverted_index.(INF)	17
abstract_inverted_index.(≥3	57
abstract_inverted_index.19.2;	127
abstract_inverted_index.2024.	46
abstract_inverted_index.3.27;	137
abstract_inverted_index.ASDAS	121, 155
abstract_inverted_index.EAMs.	157
abstract_inverted_index.Iraqi	20
abstract_inverted_index.Study	22
abstract_inverted_index.axSpA	9, 53
abstract_inverted_index.axial	177
abstract_inverted_index.fewer	185
abstract_inverted_index.index	94
abstract_inverted_index.lower	142
abstract_inverted_index.male;	104
abstract_inverted_index.serum	87, 162
abstract_inverted_index.study	31
abstract_inverted_index.ASDAS;	68
abstract_inverted_index.August	41
abstract_inverted_index.Study:	29
abstract_inverted_index.higher	182
abstract_inverted_index.links;	86
abstract_inverted_index.models	75
abstract_inverted_index.select	186
abstract_inverted_index.showed	108
abstract_inverted_index.staged	66
abstract_inverted_index.years;	102
abstract_inverted_index.(EAMs),	14
abstract_inverted_index.Baghdad	36, 60
abstract_inverted_index.Centers	38
abstract_inverted_index.Design:	23
abstract_inverted_index.Disease	63
abstract_inverted_index.Examine	1
abstract_inverted_index.Neither	158
abstract_inverted_index.appears	189
abstract_inverted_index.between	3
abstract_inverted_index.disease	10, 82
abstract_inverted_index.months)	58
abstract_inverted_index.related	160
abstract_inverted_index.smokers	105
abstract_inverted_index.whereas	129
abstract_inverted_index.Centers.	62
abstract_inverted_index.December	45
abstract_inverted_index.Duration	27
abstract_inverted_index.Logistic	74
abstract_inverted_index.Methods:	47
abstract_inverted_index.Results:	97
abstract_inverted_index.Tertiary	37, 61
abstract_inverted_index.absent).	115
abstract_inverted_index.activity	64, 89, 135, 164, 183
abstract_inverted_index.adjusted	76
abstract_inverted_index.analysis	50
abstract_inverted_index.assessed	84
abstract_inverted_index.carriers	140
abstract_inverted_index.confined	118
abstract_inverted_index.duration	83
abstract_inverted_index.inactive	120
abstract_inverted_index.measures	192
abstract_inverted_index.neutral.	190
abstract_inverted_index.p=0.04),	128
abstract_inverted_index.patients	54
abstract_inverted_index.response	18
abstract_inverted_index.smoking,	80
abstract_inverted_index.uveitis,	145
abstract_inverted_index.38.8±8.9	101
abstract_inverted_index.activity,	11
abstract_inverted_index.activity;	178
abstract_inverted_index.associate	153
abstract_inverted_index.conducted	33
abstract_inverted_index.genotypes	7, 69, 150
abstract_inverted_index.increased	131
abstract_inverted_index.p=0.001).	138
abstract_inverted_index.patients.	21
abstract_inverted_index.remission	125
abstract_inverted_index.EAMs-while	187
abstract_inverted_index.Objective:	0
abstract_inverted_index.associated	123, 180
abstract_inverted_index.determined	71
abstract_inverted_index.evaluated.	96
abstract_inverted_index.infliximab	16
abstract_inverted_index.phenotypic	173
abstract_inverted_index.protective	175
abstract_inverted_index.studyPlace	25
abstract_inverted_index.PCR‐RFLP.	73
abstract_inverted_index.dactylitis,	146
abstract_inverted_index.frequencies	143
abstract_inverted_index.unaffected.	194
abstract_inverted_index.Conclusions:	168
abstract_inverted_index.associations	2
abstract_inverted_index.modifier—CC	174
abstract_inverted_index.manifestations	13
abstract_inverted_index.Cross-sectional	24
abstract_inverted_index.Pharmacodynamic	191
abstract_inverted_index.cross-sectional	49
abstract_inverted_index.effect‐length.	167
abstract_inverted_index.extra‐articular	12
abstract_inverted_index.genotype-phenotype	85
abstract_inverted_index.“effect‐length”	93
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	3
citation_normalized_percentile.value	0.69098813
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False